Cargando…

Change of the vaginal microbiome with oral contraceptive therapy in women with polycystic ovary syndrome: a 6-month longitudinal cohort study

BACKGROUND: The association between the vaginal microbiome and polycystic ovary syndrome (PCOS) is reported, but the longitudinal changes in the vaginal microbiome that accompany oral contraceptive therapy have not been described. METHODS: This cohort study included 50 PCOS patients who wanted to ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Xiang, Qin, Pengfei, Gao, Liting, Huang, Lingling, Shi, Yong, Peng, Danhong, Wang, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693170/ https://www.ncbi.nlm.nih.gov/pubmed/38041079 http://dx.doi.org/10.1186/s12916-023-03196-9

Ejemplares similares

Clinical Manifestations of Polycystic Ovary Syndrome and Associations With the Vaginal Microbiome: A Cross-Sectional Based Exploratory Study
por: Hong, Xiang, et al.
Publicado: (2021)

Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome
por: Lu, Chaoyi, et al.
Publicado: (2021)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
por: Park, Chan-Hong, et al.
Publicado: (2020)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome
por: Tayachew, Beza, et al.
Publicado: (2022)

Characteristics of the vaginal microbiome in cross-border female sex workers in China: a case-control study
por: Hong, Xiang, et al.
Publicado: (2019)

Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
por: Rizk, Maryan G, et al.
Publicado: (2020)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2016)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
por: de Medeiros, Sebastião Freitas
Publicado: (2017)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
por: Spritzer, Poli Mara
Publicado: (2022)

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
por: Decanter, Christine, et al.
Publicado: (2013)

Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
por: Amiri, Mina, et al.
Publicado: (2020)

Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome
por: Li, Na, et al.
Publicado: (2021)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study
por: Yousuf, Syed Douhath, et al.
Publicado: (2018)

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study
por: Stefanaki, Charikleia, et al.
Publicado: (2019)

Advances in contraception: vaginal contraceptive rings
por: Al-Haddad, Sara, et al.
Publicado: (2023)

Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
por: Hassan, Saqib, et al.
Publicado: (2022)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition
por: Noël-Romas, Laura, et al.
Publicado: (2020)

Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
por: Divani, Afshin A., et al.
Publicado: (2015)

Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China
por: Li, Gailing, et al.
Publicado: (2022)

Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: de Medeiros, Sebastião Freitas, et al.
Publicado: (2018)

The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
por: Acmaz, G., et al.
Publicado: (2019)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Vaginal microbiome following orally administered probiotic
por: Hertz, Frederik Boetius, et al.
Publicado: (2022)

The elasticity of cervical-vaginal secretions is abnormal in polycystic ovary syndrome: Case report of five PCOS women
por: Shamim, Nabila, et al.
Publicado: (2012)

Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood
por: Khafagy, Ghada M., et al.
Publicado: (2021)

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
por: Behboudi-Gandevani, Samira, et al.
Publicado: (2019)

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study
por: Kumarendran, Balachandran, et al.
Publicado: (2021)

The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome
por: Kelley, Scott T., et al.
Publicado: (2016)

The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
por: Mukherjee, Anirban Goutam, et al.
Publicado: (2023)

Longitudinal Profiling of the Macaque Vaginal Microbiome Reveals Similarities to Diverse Human Vaginal Communities
por: Rhoades, Nicholas S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kgo65v6vb2uaaglfffvpot618f